23andMe
potential to use genetics to more efficiently develop novel therapeutics by power need and speed drug development is inefficient time to | 23andMe
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
28 of 57
Related slides by other companies
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
we aim to develop companion diagnostics to augment our therapeutic combinations and as | Aeglea BioTherapeutics
Asos
Results
October 2020
continuing to develop our brands at speed | Asos
Lion Electric
Investor Presentation
August 2023
technical specifications welsh top speed maximum power ranges up to miles level ill charging time minimum hours lion electric | Lion Electric
MindMed
Results
November 2023
has proven potential across multiple therapeutic areas | MindMed
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io